Catalent | CTLT - الربح الإجمالي على المبيعات



الربح الإجمالي على المبيعات تغيير تاريخ
Agilent USD 1.04B 52M 2026-06
AstraZeneca USD 13.28B 421M 2026-09
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Bruker USD 416M 36.2M 2026-06
Centene USD 3.23B 10.59B 2026-09
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cigna USD 6.08B 50.37B 2026-03
Danaher USD 3.84B 226M 2026-09
Dentsply International USD 493M 66M 2026-06
Elevance Health USD 44.33B 32.65B 2026-06
Eli Lilly USD 20.59B 886M 2026-09
Glaxosmithkline GBP 6.5B 743M 2026-09
Humana USD 4.82B 754M 2025-06
Illumina USD 830M 60M 2026-09
Intuitive Surgical USD 2.08B 60.4M 2026-09
IQVIA Holdings USD 1.18B 258M 2026-09
J&J USD 18.55B 6M 2026-09
Laboratory Of America USD 1.11B 3.9M 2026-09
Lonza CHF 1.29B 248M 2025-06
McKesson USD 3.68B 359M 2026-06
Merck EUR 3.17B 101M 2026-06
Merck USD 12.21B 121M 2026-06
Mettler Toledo International USD 555.82M 119.62M 2026-03
Novartis USD 11.42B 180M 2026-09
Pfizer USD 3.24B 3.49B 2026-09
Quest Diagnostics USD 1.01B 22M 2026-09
Repligen USD 110.99M 949K 2026-09
Revvity USD 418.58M 1.71M 2026-09
Roche Holding CHF 22.69B 600M 2026-06
Supernus Pharmaceuticals USD 176.53M 16.48M 2026-09
Thermo Fisher Scientific USD 5.2B 319M 2026-09
UnitedHealth USD 98.99B 330M 2026-09
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 986M 496M 2026-09
West Pharmaceutical Services USD 347.4M 18.2M 2026-09